Not for Distribution to U.S. Newswire Services or for Dissemination in the United States TORONTO–(BUSINESS WIRE)–Phoenix Canada Oil Company Limited (TSX-V: PCO) (“Phoenix“) and ZYUS Life Sciences Inc. (“ZYUS” or the “Company”), a private Canadian life sciences company, together announce that they have entered into a non-binding Letter of Intent dated May 27, 2022 (the … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Alzheimers Disease Therapeutics Market 2022-2026” report has been added to ResearchAndMarkets.com’s offering. The alzheimers disease therapeutics market is poised to grow by $3.99 bn during 2022-2026, accelerating at a CAGR of 8.76% The market is driven by the availability, research, and development of novel biomarkers, increasing awareness of Alzheimer’s disease, and a … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Brain Computer Interface Market Outlook 2020-2030” report has been added to ResearchAndMarkets.com’s offering. The global brain computer interface (BCI) market is anticipated to grow with a CAGR of 12.54% over the forecast period, i.e., 2021 – 2030. Companies Mentioned NextMind SAS Blackrock Neurotech Advanced Brain Monitoring Inc. NIHON KOHDEN CORPORATION g.tec medical … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “The New EU Medical Devices Regulations Training – Essential Tasks to Complete the EU MDR Implementation and Transition” training has been added to ResearchAndMarkets.com’s offering. This 2-day virtual seminar will go into the specifics of the European Union Medical Device Regulation (EU MDR), provide case studies and share lessons learned so your organization … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Refurbished Medical Equipment Market Research Report by Product, End User, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Refurbished Medical Equipment Market size was estimated at USD 29.49 billion in 2021 and expected to reach USD 32.41 billion in 2022. The … [Read more…]

Opdivo in combination with chemotherapy and Opdivo plus Yervoy® (ipilimumab) approved based on a Phase 3 trial showing improved overall survival versus chemotherapy alone1,2 Opdivo-based treatments are now approved for five indications in upper gastroesophageal cancers1 PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #CheckMate—Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has … [Read more…]

In Recognition of Mental Health Awareness Month, Report Highlights Eight Findings on How Depression is Linked to Oral Health BOSTON–(BUSINESS WIRE)–CareQuest Institute for Oral Health® — a leading national nonprofit focused on creating a more accessible, equitable, and integrated oral health system — released a new report during Mental Health Awareness Month that spotlights the … [Read more…]

NEW YORK–(BUSINESS WIRE)–Viveon Health Acquisition Corp. (NYSE: “VHAQU” or the “Company”) announces that on May 24, 2022, as a result of its inability to timely file with the Securities and Exchange Commission (“SEC”) its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2022 (the “Form 10-Q”), it received a notice from … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–Ambrx Biopharma Inc., or Ambrx, (NYSE: AMAM), a clinical stage biopharmaceutical company using an expanded genetic code technology platform to create Engineered Precision Biologics (EPBs), today announced that Feng Tian, Ph.D., Chairman of the Board, President and CEO of Ambrx, will participate in two upcoming investor conferences in June. Cowen’s 3rd Annual Oncology … [Read more…]

CHICAGO–(BUSINESS WIRE)–Exicure, Inc. (NASDAQ: XCUR), an early-stage biotechnology company focused on the development of next generation nucleic acid therapies targeting RNA to address both genetic and non-genetic neurological disorders and hair loss disorders, today announced that the Company’s Annual Meeting of Stockholders (the “Annual Meeting”) held in virtual format on Friday, May 27, 2022 at … [Read more…]